Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vascular Improvement with Olmesartan medoxomil Study

Trial Profile

Vascular Improvement with Olmesartan medoxomil Study

Phase of Trial: Phase IV

Latest Information Update: 17 Aug 2017

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Atenolol
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Acronyms VIOS
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 12 Jun 2007 Status change
    • 29 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top